Market Flash
-
![Corbus’ anabasum meets safety and tolerability goals in cystic fibrosis study]( "Corbus’ anabasum meets safety and tolerability goals in cystic fibrosis study")
Corbus’ anabasum meets safety and tolerability goals in cystic fibrosis study
2017-04-01A phase 2 trial evaluating Corbus Pharmaceuticals’ multiple doses of anabasum (Resunab) has met its primary objective in patients with cystic fibrosis, demonstrating an acceptable safety and tolerability profile with no severe adverse events.
-
-
-
-
-
-
-
-
-
-
-
Kumho Tire sale rises as election issue
2017-03-22 -
Anxiety over availability hits rubber
2017-03-22 -
-
-
-
-
-
-
U.S. Shale Is Pushing OPEC To Breaking Point
2017-03-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Hot News
-
Who are the world’s top 10 cosmetic ingredients giants?
-
What Colour Are The Black Boxes? Which Part Of The Plane Are The Black Boxes In?
-
Dual Control' in a major chemical province! Raw materials skyrocket! The supply is in a hurry!
-
Selected News of the Week (September 2-10, 2019)
-
Support standardization and promote healthy development of small food workshops
-
Guodu Chemical Resin Plant exploded, and the resin will rise again?
-
Nearly 100 chemical giants have stopped production and may be out of stock at any time!
-
The largest domestic silicone factory burst into flames! The raw materials are going to rise again!
-
What are the components of lithium battery electrolyte
-
Top 10 Global CDMO Rankings in 2022
